.navbar .collapse { display: block; } .mobile-nav { max-height: none !important; } @media screen and (min-width: 1200px) { .navbar #basic-navbar-nav .navbar-nav { position: static !important; } }

Business PracticeSee All >

Business
Development
Legal
Policy
Practice
Regulatory

About
Contact
Advisory Board
Do Not Sell My Information
Terms & Conditions
Privacy Policy

Global Perspective on the Effect of Biosimilars

EP. 1: Comparison of Biologics to Biosimilars Versus Generics

October 10th 2018

EP. 2: The BPCIA and the Naming of Biosimilars

October 10th 2018

EP. 3: The Approval Process for Biosimilars

October 10th 2018

EP. 4: Considerations for Approving Generics Versus Biosimilars

October 10th 2018

EP. 5: Interchangeability and Postmarketing Pharmacovigilance of Biosimilars

October 10th 2018

EP. 6: Experience Prescribing Biosimilars Versus Biologics

October 10th 2018

EP. 7: The Impact of Access to Biosimilars

October 10th 2018

EP. 8: US and EU Biosimilar Pricing and Stakeholder Education

October 10th 2018

EP. 9: Formulary Approval and Challenges for Payers

October 10th 2018

EP. 10: Prescribing Biosimilars and Educating Patients and Physicians

October 10th 2018